Skip to main navigation Skip to search Skip to main content

Prevention of Epstein-Barr virus lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

Translated title of the contribution: Prevention of Epstein-Barr virus lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
  • J.W.J van Esser
  • , H.G.M. Niesters
  • , B. van der Holt
  • , E. Meijer
  • , A.D.M.E. Osterhaus
  • , J.W. Gratama
  • , L.F. Verdonck
  • , B. Lowenberg
  • , J.J. Cornelissen

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPrevention of Epstein-Barr virus lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
Original languageUndefined/Unknown
Pages (from-to)4364-4369
Number of pages6
JournalBlood
Volume99
Publication statusPublished - 2002

Cite this